Strength in numbers: Join us March 31 for DO Day on Capitol Hill Register today!

The DO

Less than 62 percent of Americans know there is a vaccine for shingles, according to AOA survey

By The DO


The new FDA-approved vaccine, marketed as Shingrix, is shown to be 97 percent effective in adults ages 50-69, and more than 90 percent effective in those 70 to well past 80. The earlier vaccine, Zostavax, prevented just over half (51%) of recipients from developing the painful disease and was recommended for patients 60 and older, due to waning immunity over time.